MLS-101

IPO Doors Creak Open as Mineralys Seeks $192M
BioSpace
Fri, 02/10/23 - 10:31 am
IPOs
Mineralys Therapeutics
hypertension
MLS-101
Months removed from a $118M Series B, Mineralys pushes ahead with PhII hypertension data
Endpoints
Thu, 11/17/22 - 11:52 am
Mineralys
funding
MLS-101
hypertension